Wordt geladen...
A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret Hospital
BACKGROUND: Based on the tax 327 phase iii trial, docetaxel-based chemotherapy is the standard first-line treatment for hormone-resistant prostate cancer (hrpc); however, there is some heterogeneity in the use of this agent in routine clinical practice. The aim of the present study was to examine th...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Multimed Inc.
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2854632/ https://ncbi.nlm.nih.gov/pubmed/20404974 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|